The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer

Rhea-AI Summary

Vitrolife Group (VTRLY) has announced the appointment of Pär Ihrskog as their new Chief Financial Officer, effective October 10, 2025. Ihrskog, currently serving as CFO at Bufab Group, brings significant financial expertise from his previous roles, including his position as Group CFO/CIO at Embellence Group and various finance roles at SKF, where he gained international experience in the U.S. and China.

The new CFO holds a master's degree in business administration and will succeed Helena Wennerström, who will continue as acting CFO until Ihrskog assumes the position. CEO Bronwyn Brophy O'Connor expressed confidence that Ihrskog's extensive financial expertise and leadership experience in listed companies will support Vitrolife's strategy for sustainable profitable growth.

Positive

• Appointment of experienced CFO with international expertise
• New CFO brings leadership experience from listed companies
• Strong educational background with master's in business administration

Negative

• 6-month transition period before new CFO takes office

GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Pär Ihrskog has been appointed CFO of the Vitrolife Group effective 10 October 2025. Pär currently serves as CFO at Bufab Group and brings a wealth of experience to the company, having also served as Group CFO/CIO at Embellence Group. He spent the majority of his career working in finance roles, of increasing seniority in SKF, also living and working in several countries, including the U.S. and China. Pär holds a master's degree in business administration. 

"We are delighted to welcome Pär Ihrskog to the Vitrolife Group as CFO. His extensive financial expertise, combined with a proven track record of leadership in listed companies, brings valuable strategic and operational insight that will support the company in driving sustainable profitable growth," says Bronwyn Brophy O'Connor, CEO.

Helena Wennerström will remain as acting CFO until Pär takes office.

Gothenburg, 10 April 2025
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO

The information was submitted for publication, through the agency of the contact persons set out above, at 10-04-2025 12:00 CET.

Contact:
Amelie Wilson, Investor Relations, awilson@vitrolife.com 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/the-vitrolife-group-appoints-par-ihrskog-as-the-new-chief-financial-officer,c4134081

The following files are available for download:

https://mb.cision.com/Main/1031/4134081/3381264.pdf

The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer

 

FAQ

When will Pär Ihrskog start as CFO at Vitrolife Group (VTRLY)?

Pär Ihrskog will start as CFO at Vitrolife Group on October 10, 2025.

What is Pär Ihrskog's current role before joining Vitrolife (VTRLY)?

Pär Ihrskog currently serves as CFO at Bufab Group.

Who is the interim CFO at Vitrolife (VTRLY) until October 2025?

Helena Wennerström is serving as acting CFO until Pär Ihrskog takes office.

What international experience does the new Vitrolife (VTRLY) CFO have?

Pär Ihrskog has worked in finance roles at SKF in multiple countries, including the U.S. and China.